Gilead | The Epoch Times

FDA Approves First Treatment for COVID-19, Remdesivir

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for the treatment of adults with COVID-19, making it the first and only FDA-approved treatment for the disease ...

October 22, 2020BY Mimi Nguyen Ly

EU Buys Remdesivir to Treat 30,000 COVID Patients, Seeks More

BRUSSELS—The European Union's executive said on Wednesday it had agreed to buy a limited supply of the COVID-19 ...

July 29, 2020BY Reuters

Gilead’s $2,340 Price for Coronavirus Drug Draws Criticism

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will ...

June 30, 2020BY The Associated Press

NIH Trial: Gilead’s Drug Works Best in COVID Patients on Oxygen

The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences ...

May 23, 2020BY Reuters

Remdesivir Explained—What Makes This Drug Work Against Viruses?

With the FDA approving Gilead’s Remdesivir as an emergency use treatment for the most acute cases of COVID-19, many people ...

May 6, 2020BY The Conversation

3,000 Participants Added to Trials for Experimental COVID-19 Treatment

Gilead Sciences has increased the number of patients involved in two trials for its experimental COVID-19 treatment remdesivir. ...

April 10, 2020BY Zachary Stieber

CCP Virus Patients Rush to Join Studies of Gilead Drug

The new CCP virus made Dr. Jag Singh a patient at his own hospital. His alarm grew as ...

April 6, 2020BY The Associated Press

How Much of Our Tax Money Goes to Big Pharma? A Lot.

After an 18 month investigation into the high cost of Gilead's hepatitis C drug Sovaldi—initially listed at $84,000 ...

February 20, 2016BY Martha Rosenberg

Drug Maker Was Focused on Profits, Not Patients: Report

The makers of a breakthrough hepatitis drug put profits before patients in pricing the $1,000 pill that's become ...

December 1, 2015BY The Associated Press